Tilray | TRLY - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acasti Pharma USD 0 0 2024-12
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Avita Medical AUD 42.24M 1.25M 2024-12
Canopy Growth CAD 217.12M 7.87M 2026-03
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Moderna USD 603M 7M 2026-03
Organigram Holdings CAD 60.76M 1.77M 2026-03
Organon & Co USD 8.55B 75M 2026-03
Revvity USD 2.63B 836K 2026-03
Tectonic Therapeutic USD 17K 26K 2026-03
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 12.41B 67.1M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03
Zealand Pharma A/S 383.14M 727K 2025-12